Cargando…
Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study
INTRODUCTION: In clinical practice, nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly discontinued after response to biologic therapy is achieved in patients with axial spondyloarthritis (axSpA), but the impact of NSAID discontinuation has not been assessed in prospective controlled trials....
Autores principales: | Dougados, Maxime, Wood, Emily, Combe, Bernard, Schaeverbeke, Thierry, Miceli-Richard, Corinne, Berenbaum, Francis, Koppiker, Nandan, Dubanchet, Arnaud, Logeart, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282738/ https://www.ncbi.nlm.nih.gov/pubmed/25428762 http://dx.doi.org/10.1186/s13075-014-0481-5 |
Ejemplares similares
-
Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022) -
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
por: Maksymowych, Walter P, et al.
Publicado: (2016) -
Characterization of Blood Mucosal‐Associated Invariant T Cells in Patients With Axial Spondyloarthritis and of Resident Mucosal‐Associated Invariant T Cells From the Axial Entheses of Non‐Axial Spondyloarthritis Control Patients
por: Rosine, Nicolas, et al.
Publicado: (2022) -
Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis
por: Rosine, Nicolas, et al.
Publicado: (2018) -
Characterisation of gut microbiota composition in patients with axial spondyloarthritis and its modulation by TNF inhibitor treatment
por: Vallier, Marie, et al.
Publicado: (2023)